Cargando…

The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan

PURPOSE: Since 2020, the novel coronavirus infection (COVID-19) has spread globally. A few studies have investigated the safety of COVID-19 convalescent plasma (CCP) apheresis from COVID-19. This study was the first retrospective observational study of CCP in Japan. METHODS: We recruit donors from A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamo-Imai, Ayumi, Togano, Tomiteru, Sato, Motohiko, Kawakami, Yuiko, Inaba, Kumi, Shimazu, Hiroshi, Igarashi, Saori, Tanaka, Keiko, Terada, Mari, Kinoshita-Iwamoto, Noriko, Saito, Sho, Kutsuna, Satoshi, Hangaishi, Akira, Morioka, Shinichiro, Takahashi, Kenzo, Miyata, Satoshi, Ohmagari, Norio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027293/ https://www.ncbi.nlm.nih.gov/pubmed/36964059 http://dx.doi.org/10.1016/j.transci.2023.103687

Ejemplares similares

Preserved SARS-CoV-2 neutralizing IgG activity of in-house manufactured COVID-19 convalescent plasma
por: Inada, Makoto, et al.
Publicado: (2023)

Efficacy and Safety of Treatment with Plasma from COVID-19-Recovered Individuals
por: Terada, Mari, et al.
Publicado: (2023)

A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT)
por: Tomita, Noriko, et al.
Publicado: (2022)

Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in Japan
por: Suzuki, Tetsuya, et al.
Publicado: (2022)

The influence of pre-admission antiplatelet and anticoagulation therapy on the illness severity in hospitalized patients with COVID-19 in Japan
por: Togano, Tomiteru, et al.
Publicado: (2021)

Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
por: Suzuki, Tetsuya, et al.
Publicado: (2023)

Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection
por: Inada, Makoto, et al.
Publicado: (2022)

Prolonged and Late-Onset Symptoms of Coronavirus Disease 2019
por: Miyazato, Yusuke, et al.
Publicado: (2020)

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial
por: Saito, Sho, et al.
Publicado: (2023)

Difficulty of downscaling the precautions for coronavirus disease-19 based on negative throat polymerase chain results in the early phase of infection()
por: Suzuki, Tetsuya, et al.
Publicado: (2020)

Beau's Lines and Leukonychia in a COVID-19 Patient
por: Ide, Satoshi, et al.
Publicado: (2020)

Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012–2013 and 2018–2019
por: Nomoto, Hidetoshi, et al.
Publicado: (2020)

Correction: Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012–2013 and 2018–2019
por: Nomoto, Hidetoshi, et al.
Publicado: (2022)

We Should Pay More Attention to Sex Differences to Predict the Risk of Severe COVID-19: Men Have the Same Risk of Worse Prognosis as Women More Than 10 Years Older
por: Matsushita, Yumi, et al.
Publicado: (2023)

480. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant among Immunocompromised Patients
por: KAMEGAI, K O H E I, et al.
Publicado: (2023)

A Fatal Breakthrough COVID-19 Case Following Bendamustine-Rituximab Therapy
por: Kamegai, Kohei, et al.
Publicado: (2022)

Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A case study
por: Morioka, Shinichiro, et al.
Publicado: (2020)

Factors associated with development and persistence of post-COVID conditions: A cross-sectional study()
por: Miyazato, Yusuke, et al.
Publicado: (2022)

Hydrocele due to Wuchereria bancrofti Infection
por: Takaya, Saho, et al.
Publicado: (2018)

The Authors' Reply to “Both Macro and Micro Filarial Treatment May Be Necessary to Treat Hydrocele Due to a Wuchereria bancrofti Infection”
por: Takaya, Saho, et al.
Publicado: (2019)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective
por: Kayikcioglu, Meral
Publicado: (2021)

Evaluation of the efficacy of anticoagulation therapy in reducing mortality in a nationwide cohort of hospitalized patients with coronavirus disease in Japan
por: Hara, Hisao, et al.
Publicado: (2021)

Comparison of the clinical characteristics and outcomes of Japanese patients with COVID-19 treated in primary, secondary, and tertiary care facilities
por: Tomidokoro, Daiki, et al.
Publicado: (2023)

Factors Associated With Prolonged Psychological Distress Among Nurses and Physicians Engaged in COVID-19 Patient Care in Singapore and Japan
por: Morioka, Shinichiro, et al.
Publicado: (2022)

Dengue Virus Exported from Côte d’Ivoire to Japan, June 2017
por: Suzuki, Tetsuya, et al.
Publicado: (2017)

Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

Apheresis in Neurological Disorders
por: Dorst, Johannes
Publicado: (2020)

Apheresis and Covid-19
por: Griveas, Ioannis
Publicado: (2022)

Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis
por: Matsuyama, Ryota, et al.
Publicado: (2016)

Epidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated Candidemia
por: Ishikane, Masahiro, et al.
Publicado: (2016)

The impact of infectious disease consultation in candidemia in a tertiary care hospital in Japan over 12 years
por: Ishikane, Masahiro, et al.
Publicado: (2019)

Effect of evacuation of Japanese residents from Wuhan, China, on preventing transmission of novel coronavirus infection: A modelling study
por: Asai, Yusuke, et al.
Publicado: (2021)

Imported African Tick Bite Fever in Japan: A Literature Review and Report of Three Cases
por: Ando, Naokatsu, et al.
Publicado: (2022)

Therapeutic effect of intensive granulocyte and monocyte adsorption apheresis combined with thiopurines for steroid- and biologics-naïve Japanese patients with early-diagnosed Crohn’s disease
por: Fukuchi, Takumi, et al.
Publicado: (2014)

Surveillance and risk assessment of health screening for vaccine-preventable diseases among international students in Japan: A cross-sectional study in 2020
por: Takahata, Hanako, et al.
Publicado: (2022)

Association between Functional Capacity Decline and Nutritional Status Based on the Nutrition Screening Initiative Checklist: A 2-Year Cohort Study of Japanese Community-Dwelling Elderly
por: Sugiura, Yumiko, et al.
Publicado: (2016)

SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response
por: Takamatsu, Yuki, et al.
Publicado: (2022)

SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response
por: Takamatsu, Yuki, et al.
Publicado: (2022)

Therapeutic apheresis in autoimmune diseases
por: Bambauer, Rolf, et al.
Publicado: (2013)

Therapeutic Apheresis in Metabolic Syndrome
por: Voinov, V.A.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7jo838l5gmqkqo08smbmu2ai2m